Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?

The 3-weekly regimen of carboplatin and paclitaxel is the backbone of first line adjuvant chemotherapy for advanced ovarian cancer. The landmark Japanese Gynaecologic Oncology Group (JGOG) 3016 study demonstrated significant improvements in progression-free survival and overall survival with dose de...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Gynecol Oncol
Päätekijät: Lee, Matilda X., Tan, David SP
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Aiheet:
Review Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6189442/
https://ncbi.nlm.nih.gov/pubmed/30207104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2018.29.e96
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia